Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.35 USD | -1.61% | -5.16% | +8.89% |
13/05 | Trending : Fulcrum Therapeutics, Sanofi in Losmapimod Licensing Deal | DJ |
13/05 | Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.89% | 46Cr | |
+26.37% | 4.5TCr | |
-1.01% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.34% | 2.61TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.28TCr | |
+26.99% | 1.21TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- FULC Stock
- News Fulcrum Therapeutics, Inc.
- Transcript : Fulcrum Therapeutics, Inc., Q3 2023 Earnings Call, Nov 07, 2023